Furthermore, in various cancer types, including lung, breast, cervical, and prostate cancers, curcumin downregulates PKM2 through the inhibition of the mTOR/HIF-1α signaling pathway, which disrupts glucose uptake and lactate release. This evidence concerns the gene HIF1A and prostate cancer.